Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

Clinical trial NCT05703971 · RECRUITING

Trial details

NCT number: NCT05703971
Sponsor: Genprex, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Extensive Stage

Start date: 2024-05-09
Primary completion: 2026-06-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.